🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseEfinopegdutide MASH data — July 2024 Page 6

Efinopegdutide MASH data — July 2024

KarenAZ_mom Thu, May 30, 2024 at 2:14 PM 39 replies 2,830 viewsPage 6 of 8
nick_SD_fit
Member
278
1,234
Sep 2024
San Diego, CA
Jul 11, 2024 at 7:30 AM#26
labquiet_amy said:
Practical: whatever you change, write down the date and the reason.

I am going to disagree with the direction of travel here. The thread has converged on the tidiest answer rather than the best-supported one, and those are not the same thing.

Last edited: Jul 11, 2024 at 9:30 AM
33 6SkepticalSean, Dr.CardioMD, EndoResFellow and 30 others
Reply Quote Save Share Report
TinaHashiRN
Member
345
1,567
Sep 2024
Raleigh, NC
Jul 16, 2024 at 1:41 PM#27
labquiet_amy said:
Practical: whatever you change, write down the date and the reason.

True, and it depends on a baseline nobody has stated. Without knowing where someone started, the same number can be an excellent result or a disappointing one.

I would rather be corrected than agreed with, if it comes to it.

34 7mike_mod, SarahChen_PharmD, sarah.morrison and 31 others
Reply Quote Save Share Report
PurityPaulOR
Senior Member
1,890
7,890
Mar 2024
Oregon
Jul 21, 2024 at 7:49 PM#28
labquiet_amy said:
Practical: whatever you change, write down the date and the reason.

That reframing is the part I needed. Adding it to my notes with a link back to this thread.

35 8Admin, Dr.Martinez, mike_mod and 32 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
anna.melb_AU
Member
678
2,890
Apr 2024
Melbourne, AU
Jul 27, 2024 at 1:54 AM#29

Adding the clinical framing, because it changes how the question reads. Take it one variable at a time. Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent argument can untangle them after the fact.

Last edited: Jul 27, 2024 at 5:54 AM
36 9tammy_FL, Dr.LipidDallas, alex_tucson and 33 others
Reply Quote Save Share Report
KarenAZ_mom
Member
567
2,567
Aug 2024
Scottsdale, AZ
Aug 1, 2024 at 7:56 AM#30

Reporting back.

Reporting back for the archive rather than for the thread: I did the narrow version of what was suggested, gave it the full interval, and it settled. Posting it because threads without a follow-up are half a thread.

8 6HPLC_Greg, LibrarianMeg, bri_stats and 5 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register